ClinicalTrials.gg
Active, not recruitingNCT06429709Updated Jul 9, 2026

Utility of Advanced Ultrasound Otoscope In The Diagnosis of AOM

An observational study in Otitis Media Recurrent, Middle Ear Infection and Ear Infection, sponsored by Baylor College of Medicine. Active, not recruiting at 1 site in United States. Open to participants aged 0 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-07-09.

Sponsored by Baylor College of Medicine · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
0 Years to 12 Years
Sex
All
01

Study summary

The objective of this study is to collect ultrasound signal information and visual otoscopic images with an engineering prototype device for children scheduled for tympanostomy tube surgery for the purpose of algorithm development.

Read the detailed description

The objective of this study is to collect ultrasound signal information and visual otoscopic images with an engineering prototype device for children scheduled for tympanostomy tube surgery for the purpose of algorithm development.

After informed consent from a parent or guardian is obtained, ultrasound and visual data will be collected for each of the child's ears. The images will be taken with the Advanced Ultrasound Otoscope device. The ear laterality will be noted as well as any infection present in the fluid, non-infected fluid, or normal findings in the middle ear as reported by the surgeon. No identifiable data will be recorded. Each study participant will be given a unique study number that will be linked to the images and middle ear findings. No additional information is gathered including age, sex, name or other PHI. The images and corresponding study data will be stored on a password protected smartphone or tablet as well as on a password protected external hard drive. Other characteristics that will be collected include surgical and lab findings regarding effusion, presence or absence (i.e. effusion). The middle ear fluid which is usually suctioned will be collected in a trap chamber- Tympap- and this collected fluid will be sent to the microbiology laboratory for analysis

Investigators will be collecting ultrasound and visual data from the tympanic membrane. The images the investigators are collecting are optical images of the surface of the tympanic membrane. The waveforms do not traverse the body tissue, the tympanic membrane is a strong reflector, and the signal is returned to the ultrasound transducer for processing the waveform from an analog to a digital signal. The power of the ultrasound signal is 1/1000th of the ultrasound power used for fetal imaging which is considered safe.

02

Conditions studied

  • Otitis Media Recurrent
  • Middle Ear Infection
  • Ear Infection

Browse trials for

Keywords

  • Otoscope
  • Tympanogram
  • Effusion
  • Ultrasound
03

In context

Otitis Media

241 studies on the registry are indexed under Otitis Media; 32 are open to participants now.

This study's planned enrollment of 300 is above the median of 150 across 57 observational studies indexed under Otitis Media.

Browse Otitis Media studies →

Lead sponsor

Baylor College of Medicine is the lead sponsor of 747 studies on the registry; 110 are open to participants now.

Of its 84 completed or terminated interventional studies of FDA-regulated products, 45 (54%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The investigators will be recruiting patients between 0 months and 12 years of age who meet the listed inclusion criteria and do not meet any of the listed exclusion criteria. The investigators are not selecting patients based on race/ethnicity or gender/sex. Parents must be fluent in either English or Spanish.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Newborn to 12 years of age
  • Receiving first set of pressure equalization (PE) tubes, even if coordinated with other procedures such as adenoidectomy
  • Indication for surgery includes recurrent acute otitis media, chronic otitis media with effusion, Eustachian tube dysfunction, and/or hearing loss.

Exclusion criteria

Exclusion Criteria:

  • Cholesteatoma, tympanic membrane perforation, myringitis
  • History of PE tube placement or PE tubes currently in place.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Algorithm Development

    Ultrasound and signal information and visual otoscopic images will be collected with an engineering prototype otoscope device for children scheduled for tympanostomy tube surgery. Images of each of the child's ears will be taken by the advanced ultrasound otoscope device. Data collected will include ear laterality, surgical and lab findings of the effusion (present or absent) and characteristics as reported by the surgeon. The middle ear fluid which is usually suctioned will be collected in a trap chamber- Tympap- and this collected fluid will be send for analysis to microbiology. The pathology results will be recorded to correlate ultrasound signals to surgical findings

    Device: Advanced Ultrasound Otoscope

  • Clinical Validation

    The clinical validation phase includes the same procedures as the algorithm development phase only, the clinical validation phase is a double blind study where ultrasound score is compared to surgical findings and lab analysis.

    Device: Advanced Ultrasound Otoscope

Interventions

  • DeviceAdvanced Ultrasound Otoscope

    The Advanced Ultrasound Otoscope is a tool for visualization of the human tympanic membrane and detection of middle ear effusion type

06

What researchers measure

Primary outcomes

  1. Device Performance

    Correlations of device measurements and ultrasound data for Noninfected fluid and Bacterial Fluid to the gold standard of surgeon's findings at myringotomy.

    Time frame: 2 years and 6 months

Secondary outcomes

  1. Device Usability

    Evaluate the usability of the Advanced Ultrasound Otoscope device in pediatric patients as measured by the ability of the device to fit in subjects' external auditory canals and obtain a tympanic mobility measurement(s).

    Time frame: 1 year

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06429709
Collaborators
OtoNexus Medical Technologies, Inc.
Responsible party
Yi-Chun Carol Liu (Associate Professor, Baylor College of Medicine) — Principal investigator
First posted
May 28, 2024
Start date
Sep 1, 2021
Primary completion
May 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Jul 9, 2026

Study contacts

Yi-Chun Liu, MD
principal investigator · Baylor College of Medicine
Shraddha Mukerji, MD
study chair · Baylor College of Medicine
Jennifer Yan, MD
study chair · Baylor College of Medicine
Sonal Saraiya, MD
study chair · Baylor College of Medicine
Henri Traboulsi, MD
study chair · Baylor College of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion